$RVMD 8-K SEC Filings

Filed On	Filing
13 Oct 2026	8-K: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Other Events The information set forth under Item 8.01 below under the heading “Royalty Pharma Tranche A Loan” is incorporated by reference into this Item 2.03.
01 Sep 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
26 Aug 2026	8-K: Other Events
05 Aug 2026	8-K: Results of Operations and Financial Condition
22 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
06 May 2026	8-K: Results of Operations and Financial Condition
17 Apr 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
16 Apr 2026	8-K: Other Events
13 Apr 2026	8-K: Other Events
25 Feb 2026	8-K: Results of Operations and Financial Condition
05 Nov 2025	8-K: Results of Operations and Financial Condition
17 Oct 2025	8-K: Other Events
10 Sep 2025	8-K: Other Events
06 Aug 2025	8-K: Results of Operations and Financial Condition
27 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
24 Jun 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
18 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation
07 May 2025	8-K: Results of Operations and Financial Condition
26 Feb 2025	8-K: Results of Operations and Financial Condition
05 Dec 2024	8-K: Other Events

Comments